Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Bonita Insider Profile
4 Followers
David Bonita, Director at Loxo Oncology, holds 7.93M shares in Ikena Oncology (Ticker: IKNA), holds 20.82K shares in Acutus Medical (Ticker: AFIB), holds 10.65M shares in Prelude Therapeutics (Ticker: PRLD).
Profitable Transactions
8 out of 20 Profitable Transactions
Average Return
-20.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Bonita holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Bonita
David Bonita's Trading History
Loxo Oncology
Dec 12, 2017
―
Informative Sell
20.63M
$220.82M
Viewray
Apr 25, 2018
Director, Ten Percent Owner
Uninformative Buy
―
$113.82K
Tricida
Nov 25, 2022
―
Informative Sell
2.21M
$0.00
Enliven Therapeutics
Jul 16, 2021
Director, Ten Percent Owner
Informative Buy
10.00M
$72.14M
Repare Therapeutics
Sep 08, 2021
Director
Uninformative Sell
274.79K
$307.81K
Acutus Medical
Jun 15, 2023
Director
Uninformative Buy
―
$3.46K
Prelude Therapeutics
May 24, 2023
Director, Ten Percent Owner
Informative Buy
5.00M
$43.33M
Ikena Oncology
Sep 14, 2023
Director
Uninformative Buy
―
$10.31M
Third Harmonic Bio, Inc.
Sep 21, 2022
Director, Ten Percent Owner
Uninformative Buy
―
$62.59M
Ambit
May 24, 2013
―
Informative Buy
233.37K
―
List of latest transactions for each holding click on a transaction to see David Bonita's performance on stock
You May Also Like
David Bonita insider profile FAQ
What is the percentage of profitable transactions made by David Bonita?
The percentage of profitable transactions made by David Bonita is 40%.
What is the average return per transaction made by David Bonita?
The average return per transaction made by David Bonita is -20.50%.
What stocks does David Bonita hold?
David Bonita holds: LOXO, VRAYQ, TCDAQ, ELVN, RPTX, AFIB, PRLD, IKNA, THRD, ~AMBI stocks.
What was David Bonita’s latest transaction?
David Bonita latest transaction was an Uninformative Buy of ―.
What was David Bonita's most profitable transaction?
David Bonita’s most profitable transaction was an Informative Buy of VRAYQ stock on January 20, 2017. The return on the trade was 110.20%.
What is David Bonita's role in Loxo Oncology?
David Bonita's role in Loxo Oncology is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.